The present invention relates the use of fluorinated triazoles in treating neuropathic pain and affective and attention disorders including bipolar mood disorders. A pharmaceutical composition for the treatment of neurophatic pain and affective and attention disorders comprising an effective amount of a compound of formula I, wherein Ph is an o-fluorinated phenyl radical which may be additionally substituted by 1 or 2 halogen atoms selected from fluorine and chlorine, R1 is hydrogen, carbamoyl, N-(C2-C5)alkanoylcarbamoyl or N,N-di(C1-C4)alkylcarbamoyl, and R2 is carbamoyl, N-(C2-C5)alkanoylcarbamoyl or N,N-di(C1-C4)alkylcarbamoyl, in association with one or more pharmaceutical carrier or diluent.
